EN | RU
EN | RU

Help Support

Back

Vonoprazan/high-dose Amoxicillin dual therapy is safe first-line therapy for H. pylori eradication

H. pylori H. pylori
H. pylori H. pylori

What's new?

In  H. pylori-infected people,Vonoprazan/high-dose Amoxicillin dual therapy has a good eradication rate and is a safe first-line therapy.

Vonoprazan 20 mg twice daily along with Amoxicillin 500 mg four times daily dual therapy is a safe standard first-line therapy for H. pylori elimination. The effectiveness and safety of Vonoprazan and high-dose (500 mg four times daily, 2000 mg/day) Amoxicillin dual therapy for the treatment of H. pylori has not yet been evaluated in an interventional trial. This prospective, dual-center, single-arm interventional trial sought to investigate whether this was a suitable first-line therapy.

Twenty H. pylori-positive individuals with no prior history of eradication received a 7-day course of treatment that included 20 mg Vonoprazan twice daily and 500 mg Amoxicillin four times daily. A test for H. pylori antigen in the stool was used to determine eradication. Using patient questionnaires, safety was assessed. The intention-to-treat (ITT) and per-protocol (PP) eradication rates are shown in Table 1:

No significant adverse event was noted. Thus, dual therapy using Vonoprazan and high-dose Amoxicillin appears to be a safe first-line treatment.

Source:

JGH Open

Article:

Vonoprazan and high-dose amoxicillin dual therapy for Helicobacter pylori first-line eradication: A single-arm, interventional study

Authors:

Soichiro Sue et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: